Coverage dated October 31, 2021 to November 1, 2021
Indonesia becomes 1st country to greenlight Novavax COVID-19 vaccine
Headline from FOX 5 New York
Biotechnology company Novavax says that Indonesia has given the world’s first emergency use authorization for its COVID-19 vaccine, which uses a different technology than current shots.
FOX 5 New York's own description from its feed. We collect headlines and these descriptions, not full articles; read the original reporting below.
Novavax says Indonesia has given the world’s first emergency use authorization for its COVID-19 vaccine, which uses a different technology than current shots.
JAKARTA, Indonesia (AP) — Biotechnology company Novavax said Monday that Indonesia has given the world's first emergency use authorization for its COVID-19 vaccine, which uses a different technology than current
The shot marks the first time an older, protein-based shot has been approved to fight Covid-19 and the first vaccine Novavax has been able to bring to market in its 34-year history.
Indonesia, hard-hit by the coronavirus pandemic, became the first country to approve the new vaccine for Covid-19 created by US-based Novavax, the company announced Monday.
Biotechnology company Novavax says that Indonesia has given the world’s first emergency use authorization for its COVID-19 vaccine, which uses a different technology than current shots.
The two-dose vaccine, which is easier to transport and store than other shots, could play an important role in increasing supplies in developing countries.
